AvroBio Inc

NASDAQ:AVRO  
0.78
+0.01 (+1.79%)
Earnings Announcements

Avrobio Reports Fourth Quarter And Fiscal Year 2021 Financial Results

Published: 03/17/2022 11:25 GMT
AvroBio Inc (AVRO) - Avrobio Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides Business Update.
As of Dec.
31, 2021, Avrobio Had $189.6 Million in Cash and Cash Equivalents.
Avrobio-expects Cash, Cash Equivalents As of Dec 31, 2021 Will Enable Co to Fund Its Operating Expenses, Capital Expenditure Requirements Into Q1 2024.
Qtrly Loss per Share $0.65.
Q4 Earnings per Share View $-0.74 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.57

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.56

More details on our Analysts Page.